University Hospitals Birmingham NHS Foundation Trust

Search results for ""

Status Drug name NICE TAs Comments
Status: Red Cyclophosphamide tablets

For oncology
Status: Red Cyclophosphomide

Neurology indication
Status: Amber Cyproterone acetate
Status: Amber Cyproterone tablets
Status: Red Cytarabine injection

Funding approval should be sought before initiation
Status: Red Cytarabine liposomal injection

For hospital use only
Status: Red Cytarabine–daunorubicin liposomal (Vyxeos®)
Status: Amber Dabigatran capsules

Following diagnosis of AF – use in line NICE and toolkit, initiation/recommendation by haematologist, transfer to GP with RICaD. For the treatment and secondary prevention of DVT and/or PE - use in line with NICE. Initiation/recommendation by haematologist, transfer to GP with RICaD

Adults only
Status: Red Dabigatran capsules #2.8

Use following hip and knee surgery – full course of treatment supplied on discharge
Status: Red Dabrafenib
Building healthier lives
Back to top